Home
AI Agent
Annotations
Watchlists
Files

Pricing and plans
Get the full experience
We save the real magic for signed-in users.

BIIB US

Biogen Inc.(BIIB US)

$250.69-3.151.24%Ext:$245.05-5.642.25%(Market Closed · 23:55:35 UTC)

Overview

Profile Entity Structure

Documents

Categorized Chronological By Owner

SEC Filings

Financials(127)

10-QQ2ended 30 Jun 202629 Jul
10-QQ1ended 31 Mar 202629 Apr
10-KFY 2025ended 31 Dec 20256 Feb
10-QQ3ended 30 Sept 202530 Oct 2025
10-QQ2ended 30 Jun 202531 Jul 2025
10-QQ1ended 31 Mar 20251 May 2025
10-KFY 2024ended 31 Dec 202412 Feb 2025
10-QQ3ended 30 Sept 202430 Oct 2024
10-QQ2ended 30 Jun 20241 Aug 2024
10-QQ1ended 31 Mar 202424 Apr 2024
10-KFY 2023ended 31 Dec 202314 Feb 2024
10-QQ3ended 30 Sept 20238 Nov 2023
10-QQ2ended 30 Jun 202325 Jul 2023
10-QQ1ended 31 Mar 202325 Apr 2023
10-KFY 2022ended 31 Dec 202215 Feb 2023

Events(297)

8-KResults of Operations and Financial Condition29 Jul
8-KResults of Operations and Financial Condition1 Jul
8-KSubmission of Matters to a Vote of Security Holders10 Jun
8-K/AFinancial Statements and Exhibits10 Jun
8-KBiogen Completes Acquisition of Apellis Pharmaceuticals14 May
8-KResults of Operations and Financial Condition29 Apr
8-KResults of Operations and Financial Condition6 Apr
8-KTENDER AND SUPPORT AGREEMENT31 Mar
8-KDeparture of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers11 Mar
8-KDeparture of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers11 Feb
8-KResults of Operations and Financial Condition6 Feb
8-KResults of Operations and Financial Condition13 Jan
8-KResults of Operations and Financial Condition30 Oct 2025
8-KResults of Operations and Financial Condition14 Oct 2025
8-KResults of Operations and Financial Condition31 Jul 2025

Insider Ownership(1.7K)

4Godbout Sean5 Oct
4Parini Michael3 Sep
3Parini Michael12 Aug
4Minor Lloyd5 Aug
4HAWKINS WILLIAM A11 Jun
4SHERWIN STEPHEN A11 Jun
4Rowinsky Eric K11 Jun
4Mantas Jesus B11 Jun
4LANGER SUSAN11 Jun
4Patolawala Monish D11 Jun
4Pangalos Menelas N11 Jun
4Minor Lloyd11 Jun
4Freire Maria C11 Jun
4Keeney Adam5 May
3BIOGEN INC.6 Apr

Beneficial Ownership(205)

SC 13G/ABIOGEN INC.6 Aug
SC 13G/ABIOGEN INC.5 Jun
SC 13D/AApellis Pharmaceuticals, Inc.14 May
SC 13G/ABIOGEN INC.6 May
SC 13GBIOGEN INC.29 Apr
SC 13DApellis Pharmaceuticals, Inc.6 Apr
SC 13G/ABIOGEN INC.26 Mar
SC 13GBIOGEN INC.5 Feb
SC 13G/ABIOGEN INC.13 Nov 2025
SC 13GBIOGEN INC.10 Nov 2025
SC 13D/ASage Therapeutics, Inc.30 Jul 2025
SC 13D/ASage Therapeutics, Inc.21 Jul 2025
SC 13G/ABIOGEN INC.17 Apr 2025
SC 13DSage Therapeutics, Inc.10 Jan 2025
SC 13G/ABIOGEN INC.12 Nov 2024

Other Ownership(22)

144Minor Lloyd4 Aug
144Minor Lloyd3 Aug
144Singhal Priya9 Feb
144Singhal Priya2 Feb
144Singhal Priya2 Sep 2025
144Izzar Rachid8 Jul 2025
144Singhal Priya19 May 2025
144SHERWIN STEPHEN A7 Mar 2025
144Singhal Priya9 Dec 2024
144Singhal Priya3 Sep 2024
144Singhal Priya2 Apr 2024
144Singhal Priya22 Feb 2024
144Singhal Priya21 Feb 2024
144Singhal Priya12 Feb 2024
144Singhal Priya2 Feb 2024

Proxies(167)

ARSAnnual report to security holders28 Apr
DEFA14ADefinitive additional materials28 Apr
DEF 14ADefinitive proxy statement28 Apr
DEFA14ADefinitive additional materials2 Jun 2025
DEFA14ADefinitive additional materials28 Apr 2025
DEF 14ADefinitive proxy statement28 Apr 2025
ARSAnnual report to security holders28 Apr 2025
DEF 14ADefinitive proxy statement26 Apr 2024
DEFA14ADefinitive additional materials26 Apr 2024
ARSAnnual report to security holders26 Apr 2024
PRE 14APreliminary proxy statement12 Apr 2024
DEFA14ADefinitive additional materials31 Jul 2023
DEFA14ADefinitive additional materials28 Jul 2023
DEFA14ADefinitive additional materials13 Jun 2023
DEFR14ADefinitive revised proxy statement13 Jun 2023

Registrations(98)

424B2Prospectus filing (Rule 424(b)(2))8 May 2025
424B2Prospectus filing (Rule 424(b)(2))6 May 2025
FWPFree writing prospectus6 May 2025
S-3ASRAutomatic shelf registration statement (S-3)1 May 2025
S-8Registration statement (employee benefit plan)20 Jun 2024
POS AMPost-effective amendment (unspecified)6 Jul 2022
424B3Prospectus filing (Rule 424(b)(3))26 May 2022
S-4Registration statement (business combination)17 May 2022
424B2Prospectus filing (Rule 424(b)(2))27 Apr 2020
S-3ASRAutomatic shelf registration statement (S-3)24 Apr 2020
S-8Registration statement (employee benefit plan)16 Jun 2017
FWPFree writing prospectus11 Sep 2015
424B2424(B)(2)11 Sep 2015
424B2Prospectus filing (Rule 424(b)(2))10 Sep 2015
S-3ASRAutomatic shelf registration statement (S-3)8 Sep 2015

Filing Review Correspondence(15)

CORRESPFiling review correspondence24 May 2022
CORRESPFiling review correspondence21 Jun 2021
CORRESPFiling review correspondence9 Jun 2021
CORRESPFiling review correspondence7 Apr 2021
CORRESPFiling review correspondence28 Jun 2018
CORRESPFiling review correspondence10 May 2017
CORRESPFiling review correspondence4 Apr 2017
UPLOADFiling review upload22 Apr 2009
UPLOADFiling review upload17 Apr 2009
UPLOADFiling review upload10 Apr 2009
UPLOADFiling review upload28 Apr 2008
UPLOADFiling review upload28 Apr 2008
CORRESPFiling review correspondence2 Apr 2008
UPLOADFiling review upload22 Mar 2008
UPLOADFiling review upload17 Jan 2007

SEC Orders And Notices(5)

EFFECTNotice of effectiveness12 Jul 2022
EFFECTNotice of effectiveness26 May 2022
CT ORDERConfidential treatment order29 Mar 2016
CT ORDERConfidential treatment order29 Apr 2013
CT ORDERConfidential treatment order15 Mar 2011

Tender Offers And Going Private(21)

SC TO-T/ATender offer statement (third-party, amendment)14 May
SC TO-T/AAMENDMENT NO. 212 May
SC TO-T/AAMENDMENT NO. 16 May
SC TO-TTender offer statement (third-party)14 Apr
SC TO-CSCHEDULE TO7 Apr
SC TO-CSCHEDULE TO3 Apr
SC TO-CTender offer statement (communication)31 Mar
SC TO-CSCHEDULE TO31 Mar
SC TO-T/ATender offer statement (third-party, amendment)17 Dec 2009
SC TO-T/ATender offer statement (third-party, amendment)15 Dec 2009
SC TO-T/ATender offer statement (third-party, amendment)11 Dec 2009
SC TO-T/ATender offer statement (third-party, amendment)3 Dec 2009
SC TO-T/ATender offer statement (third-party, amendment)16 Oct 2009
SC TO-T/ATender offer statement (third-party, amendment)7 Oct 2009
SC TO-T/ABIOGEN IDEC INC.22 Sep 2009

Other(9)

NO ACTAUTO-GENERATED PAPER DOCUMENT23 Feb 2017
NO ACTAUTO-GENERATED PAPER DOCUMENT13 Mar 2012
PRES14APRES14A21 Oct 1999
10-K40510-K40531 Mar 1999
10-K405/A10-K405/A3 Mar 1998
10-K40510-K40527 Feb 1998
8-B12G8-B12G2 Jun 1997
10-K40510-K40531 Mar 1997
10-C10-C21 Jun 1996

Financials & Metrics

Financials Charting Short Interest Employees